Skip to content

Home
Company
Science
- Evorpacept
- Publications
Pipeline
- Clinical Trials
- Expanded
  Access Policy
Careers
- Current Jobs
Investors
Contact

A Phase 2 Study of Evorpacept, Cetuximab, and Pembrolizumab in Patients with Refractory Microsatellite Stable Metastatic Colorectal Cancer

Post navigation

Previous: A Phase 1 Investigator-Initiated Trial of Evorpacept (ALX148), Lenalidomide and Rituximab for Patients with Relapsed or Refractory B-Cell non-Hodgkin lymphoma

Next: A Phase 1a Study of Evorpacept plus Enfortumab Vedotin in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Home
Company
Science
- Evorpacept
- Publications
Pipeline
- Clinical Trials
- Expanded
  Access Policy
Careers
- Current Jobs
Investors
Contact

© ALX Oncology Inc., All rights reserved.
Privacy Policy Twitter LinkedIn Level Access